Pharma-Tech

pharmatech.com.eg

Pharma-Tech is an Egyptian joint stock company established in 2006.Here at Pharma-Tech we inspire for good health and better quality of life by offering a wide range of carefully selected products that will help millions of people live their lives better and healthier.we aim to touch people lives not just in Egypt but also in Middle East, Africa, and Europe. We will be involved in different therapeutic areas to help challenge the most feared diseases of our time like Osteoporosis, hyperprolactinemia, and hepatitis. At pharma-Tech we believe in the concept of “pain free hospitals” that’s why we will be offering different products in pain management.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

National Medtech & Biotech Summit 2024

Conference

2024 AAPS NATIONAL BIOTECHNOLOGY CONFERENCE

Conference

Related News

Business Insights, PHARMA TECH

SIMULATIONS PLUS ENTERS NEW STRATEGIC COLLABORATION TO DISCOVER ANTICANCER THERAPIES THROUGH ITS AI-DRIVEN DRUG DESIGN TECHNOLOGY

Businesswire | March 29, 2023

Simulations Plus, Inc. a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it established a strategic research collaboration with the Sino-American Cancer Foundation (SACF). This collaboration will leverage Simulations Plus’ staff and Artificial Intelligence-driven Drug Design technology in the ADMET Predictor® software platform to support the discovery and design of novel inhibitors of methylenetetrahyd...

Business Insights

ADITXT, INC. SUCCESSFULLY COMPLETES PRECLINICAL TOXICITY STUDY OF ITS PSORIASIS DRUG CANDIDATE ADI™-100 ADVANCING IT CLOSER TO FIRST-IN-HUMAN TRIALS

Aditxt | July 11, 2022

Aditxt, Inc. a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system, today announces that its therapeutic program Adimune™, has successfully completed a toxicology study that indicates the safety profile of ADI™-100, the Company’s immunotherapeutic technology drug that addresses rejection of transplanted organs, skin allografting, autoimmune diseases and allergies. The toxicology findings...

VACCINE HEROES? COVID-19 PITFALLS, PRICING PUT PHARMA ON THE SPOT

Fiercepharma | June 16, 2020

Pharma is looking to reset its image with COVID-19 vaccines and treatments, but landmines loom—with pricing likely the biggest. The halo from pharma’s rapid response in research and discovery—and the hope that a vaccine or effective treatments will allow the world to return to some sort of normal—has propelled the industry’s reputation at an all-time high. Forty percent of Americans say their opinion of the pharma industry has turned positive during the COVID-19 pan...

CORONAVIRUS TRACKER: GSK, SANOFI BURNED BY WARP SPEED PICKS; EU MEMBERS LAUNCH COVID VAX ALLIANCE

Fiercepharma | June 04, 2020

The Trump administration unveiled its finalists for Operation Warp Speed on Wednesday afternoon, with a notable Big Pharma bent. Meanwhile, Novavax—whose shot did not make the cut—recruited Japanese manufacturer AGC Biologics to churn out adjuvant for its coronavirus vaccine candidate. And on the heels of a controversial report by the Lancet, the New England Journal of Medicine published data showing hydroxychloroquine didn't do much to prevent infection in people exposed to the ...

Business Insights, PHARMA TECH